Note that some links will break as pages are moved, websites are abandoned, etc.
If this happens, please try searching for the page in the Wayback Machine at www.archive.org.
A federal judge has approved a stipulated agreement under which the marketers of Kinoki Foot Pads- Yehuda Levin and his company, Xacta 3000, Inc.- are barred from promoting or selling any dietary supplement, food, drug, or medical device, and from helping others do the same. FTC news release, (4th November 2010)
NOTE: In 2009, the FTC charged the marketers with falsely claiming that when applied to the soles of the user's feet at night, the pads would remove toxins, metabolic wastes, heavy metals, and chemicals from the body; treat headaches, depression, parasites, fatigue, insomnia, diabetes, arthritis, high blood pressure, cellulite, and a weakened immune system; and cause weight loss. The defendants agreed to a judgment of $14.5 million, which represents the total revenues from the sale of the pads. However, based on their inability to pay, the entire judgment is suspended but will become due if they are found to have misrepresented their financial condition.